Desmond Pink

617 total citations
29 papers, 395 citations indexed

About

Desmond Pink is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Desmond Pink has authored 29 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Desmond Pink's work include Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (4 papers) and Prostate Cancer Treatment and Research (4 papers). Desmond Pink is often cited by papers focused on Extracellular vesicles in disease (9 papers), MicroRNA in disease regulation (4 papers) and Prostate Cancer Treatment and Research (4 papers). Desmond Pink collaborates with scholars based in Canada, United States and New Zealand. Desmond Pink's co-authors include John D. Lewis, Andries Zijlstra, Andrew W. Stadnyk, Ronald B. Moore, Missag H. Parseghian, Kyle Potts, Adam Kinnaird, Mary Hitt, Nawaid Usmani and Trevor H. Stenson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Desmond Pink

27 papers receiving 389 citations

Peers

Desmond Pink
Arati Limaye United States
Joerg H.O. Garbe Switzerland
Kelly Hodge United Kingdom
Desmond Pink
Citations per year, relative to Desmond Pink Desmond Pink (= 1×) peers Xiangyi Shi

Countries citing papers authored by Desmond Pink

Since Specialization
Citations

This map shows the geographic impact of Desmond Pink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desmond Pink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desmond Pink more than expected).

Fields of papers citing papers by Desmond Pink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Desmond Pink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desmond Pink. The network helps show where Desmond Pink may publish in the future.

Co-authorship network of co-authors of Desmond Pink

This figure shows the co-authorship network connecting the top 25 collaborators of Desmond Pink. A scholar is included among the top collaborators of Desmond Pink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Desmond Pink. Desmond Pink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monyror, John, Vilasrao J. Kadam, Luis Carlos Morales, et al.. (2025). Gangliosides modulate the secretion of extracellular vesicles and their misfolded protein cargo. Science Advances. 11(38). eady5212–eady5212.
2.
Cooper, Tyler T., Gabrielle M. Siegers, Desmond Pink, et al.. (2024). Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer. Journal of Ovarian Research. 17(1). 5 indexed citations
3.
Hyndman, M. Eric, Robert J. Paproski, Adam Kinnaird, et al.. (2024). Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform. npj Digital Medicine. 7(1). 163–163. 3 indexed citations
4.
Luo, Xuan, Yuzhen Tian, Jingyun Lee, et al.. (2024). Inflammatory pain resolution by mouse serum-derived small extracellular vesicles. Brain Behavior and Immunity. 123. 422–441. 2 indexed citations
5.
Pink, Desmond, Arghya Basu, Juliana Valencia, et al.. (2023). Antibody titrations are critical for microflow cytometric analysis of extracellular vesicles. Cytometry Part A. 103(8). 670–683.
6.
Fairey, Adrian, Robert J. Paproski, Desmond Pink, et al.. (2023). Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy. Cancer Medicine. 12(15). 15797–15808. 4 indexed citations
7.
Moitra, Subhabrata, Desmond Pink, John D. Lewis, et al.. (2023). SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 Patients. Viruses. 15(2). 556–556. 7 indexed citations
8.
Villalobos-Labra, Roberto, Floor Spaans, Tamara Sáez, et al.. (2022). Placenta-derived extracellular vesicles from preeclamptic and healthy pregnancies impair ex vivo vascular endothelial function. Bioscience Reports. 42(12). 16 indexed citations
9.
Baccouche, Alexandre, et al.. (2022). Model Atmospheric Aerosols Convert to Vesicles upon Entry into Aqueous Solution. ACS Earth and Space Chemistry. 7(1). 252–259. 4 indexed citations
10.
Potts, Kyle, et al.. (2021). Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma. Cancer Letters. 526. 168–179. 3 indexed citations
12.
Dinakaran, Deepak, Desmond Pink, Arun Raturi, et al.. (2020). PEG-PLGA nanospheres loaded with nanoscintillators and photosensitizers for radiation-activated photodynamic therapy. Acta Biomaterialia. 117. 335–348. 35 indexed citations
13.
Lewis, John D., et al.. (2020). Abstract PR12: Detection of EV-based signatures in prostate cancer using microflow cytometry and machine learning. Clinical Cancer Research. 26(11_Supplement). PR12–PR12. 4 indexed citations
14.
Potts, Kyle, Desmond Pink, Krista M. Vincent, et al.. (2017). Deletion of F4L (ribonucleotide reductase) in vaccinia virus produces a selective oncolytic virus and promotes anti‐tumor immunity with superior safety in bladder cancer models. EMBO Molecular Medicine. 9(5). 638–654. 36 indexed citations
15.
Kinnaird, Adam, Peter Dromparis, Bruno Saleme, et al.. (2016). Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. European Urology. 69(4). 734–744. 62 indexed citations
16.
Pink, Desmond, Keith A. Luhrs, Longen Zhou, et al.. (2015). High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model. Scientific Reports. 5(1). 15756–15756. 7 indexed citations
17.
Pink, Desmond, et al.. (2012). Real-Time Visualization and Quantitation of Vascular Permeability In Vivo: Implications for Drug Delivery. PLoS ONE. 7(3). e33760–e33760. 37 indexed citations
18.
Pink, Desmond, Stephanie Gatrell, Rajavel Elango, et al.. (2011). Lysine α-ketoglutarate reductase, but not saccharopine dehydrogenase, is subject to substrate inhibition in pig liver. Nutrition Research. 31(7). 544–554. 20 indexed citations
19.
Zhang, Yi, Desmond Pink, Kyle D. Phipps, et al.. (2010). Sensitivity of Cancer Cells to Truncated Diphtheria Toxin. PLoS ONE. 5(5). e10498–e10498. 30 indexed citations
20.
Schüler, Martin, M Zeile, Desmond Pink, et al.. (2008). Incidence of bone metastases in GIST: A single center analysis of 307 patients with metastatic disease. Journal of Clinical Oncology. 26(15_suppl). 10565–10565. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026